QSS
ACHN

Quantitative Systematic Strategies’s Achillion Pharmaceuticals ACHN Stock Holding History

Quantitative Systematic Strategies’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,059
Closed -$89K – 930
2018
Q3 		$89K Buy
+24,059
New +$71.7K 0.02% 579
2015
Q3 		– Sell
-13,496
Closed -$118K – 581
2015
Q2 		$118K Sell
13,496
-34,479
-72% -$326K 0.03% 486
2015
Q1 		$491K Buy
47,975
+28,199
+143% +$352K 0.13% 202
2014
Q4 		$243K Buy
+19,776
New +$242K 0.1% 252

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Quantitative Systematic Strategies's ACHN Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Achillion Pharmaceuticals (ACHN) in Q4 2018, closing a stake of 24,059 shares — an estimated $89K sold.

Quantitative Systematic Strategies first reported a position in ACHN in Q4 2014 and held it in 4 quarters. The position peaked at $491K in Q1 2015. 121 funds tracked by Wall St. Rank hold ACHN as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Achillion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 24,059 Achillion Pharmaceuticals shares in Q4 2018, an estimated $89K.
  • Quantitative Systematic Strategies first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Achillion Pharmaceuticals position peaked at $491K in Q1 2015.
  • 121 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.